European Archives - Page 509 of 1200 - European Medical Journal

EMJ Allergy & Immunology 8 [Supplement 1] 2023

This symposium, which took place on 1st December 2022 as part of the European Academy of Allergy and Clinical Immunology (EAACI) FAAM-EUROBAT Digital Conference presented new…

The Emerging Role of HRD Testing and the Progress of PARP Inhibitors in Ovarian Cancer

In this EMJ podcast episode, David O’Malley, Director of Gynecologic Oncology, Ohio State University, and the James Comprehensive Cancer Center, Columbus, Ohio, USA, and Christina Fotopoulou, Consultant Gynaecological Oncologist…

Radical Radiotherapy in Sinonasal Myopericytoma

The current study reports a case of extended maxillary sinus myopericytoma, diagnosed following the development of an early bulky recurrence 3 months after surgical excision…

ERS symposium recap: “Re-IMAGinING the pathway for clinical decision making in rare lung diseases – moving towards a united vision”

This EMJ podcast explores key topics addressed at the European Respiratory Society (ERS) International Congress 2022, during a symposium…

Interview: Radhika Polisetty

EMJ spoke to Radhika Polisetty about her research into antimicrobial stewardship, antimicrobial resistance, and much more.

Utilising data lakes in pharma

Pharma’s data lake is increasing in size. Read to find out how the industry can use it to its best advantage.

Pharma voted second most trusted industry in Britain

The pharmaceutical industry is the second most trusted sector in Great Britain, according to the latest Ipsos Trustworthiness Index.

The Latest Advancements in Ovarian Cancer Care Featured at ESMO 2022

In this episode of the EMJ Podcast, Brigitte Scott hosts Gilles Freyer, Medical Oncologist, Lyon University Hospital, France; and Domenica Lorusso, Associate Professor of Obstetrics and Gynecology, Catholic University of Rome, Italy…

Editor's Pick: Hypertension in Patients Receiving Dialysis: A Review of the Current Clinical Approach

Hypertension is a common complication in advanced chronic kidney disease (CKD), occurring in approximately 80–85% of patients. Blood…

Moderna becomes latest ABPI member

Moderna has become the latest member of the ABPI as part of its long-term commitment to expand in the UK.